Literature DB >> 10783355

Fifteen years experience with an in-vitro fertilization surrogate gestational pregnancy programme.

J M Goldfarb1, C Austin, B Peskin, H Lisbona, N Desai, J R de Mola.   

Abstract

The purpose of our study was to review and evaluate retrospectively the experience of an in-vitro fertilization (IVF) surrogate gestational programme in a tertiary care and academic centre. In a 15 year period from 1984 to 1999, a total of 180 cycles of IVF surrogate gestational pregnancy was started in 112 couples. On average, the women were 34.4 +/- 4.4 years of age, had 11.1 +/- 0.72 oocytes obtained per retrieval, 7.1 +/- 0.5 oocytes fertilized and 5. 8 +/- 0.4 embryos subsequently cleaved. Sixteen cycles (8.9%) were cancelled due to poor stimulation. Except for six cycles (3.3%) where there were no embryos available, an average of 3.2 +/- 0.1 embryos was transferred to each individual recipient. The overall pregnancy rate per cycle after IVF surrogacy was 24% (38 of 158), with a clinical pregnancy rate of 19% (30 of 158), and a live birth rate of 15.8% (25 of 158). When compared to patients who underwent a hysterectomy, individuals with congenital absence of the uterus had significantly more oocytes retrieved (P < 0.006), fertilized, cleaved and more embryos available for transfer despite being of comparable age. IVF surrogate gestation is an established, yet still controversial, approach to the care of infertile couples. Take-home baby rates are comparable to conventional IVF over the same 15 year span in our programme. Patients with congenital absence of the uterus responded to ovulation induction better than patients who underwent a hysterectomy, perhaps due in part to ovarian compromise from previous surgical procedures.

Entities:  

Mesh:

Year:  2000        PMID: 10783355     DOI: 10.1093/humrep/15.5.1075

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

Review 1.  Domestic and international surrogacy laws: implications for cancer survivors.

Authors:  Kiran Sreenivas; Lisa Campo-Engelstein
Journal:  Cancer Treat Res       Date:  2010

2.  Gestational carriers: A viable alternative for women with medical contraindications to pregnancy.

Authors:  Raymond M Anchan; Stacey A Missmer; Katharine F Correia; Elizabeth S Ginsburg
Journal:  Open J Obstet Gynecol       Date:  2013-07-01

3.  Gestational surrogacy. Medical, psychological and legal aspects: 9 years of experience in Mexico.

Authors:  R Cabra; A Alduncin; J R Cabra; L H Ek; M Briceño; P B Mendoza
Journal:  Hum Reprod Open       Date:  2018-01-29

4.  Non-commercial surrogacy: an account of patient management in the first Dutch Centre for IVF Surrogacy, from 1997 to 2004.

Authors:  Sylvia Dermout; Harry van de Wiel; Peter Heintz; Kees Jansen; Willem Ankum
Journal:  Hum Reprod       Date:  2009-11-27       Impact factor: 6.918

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.